Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aphrothiti J Hanrahan

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cancer Research|January 5, 2022
BRAF Mutations: The Discovery of Allele- and Lineage-Specific DifferencesAphrothiti J Hanrahan, David B Solit
Cancer Discovery|August 14, 2012
RAF/MEK dependence of KRAS-mutant pancreatic ductal adenocarcinomasAphrothiti J Hanrahan, David B Solit
Nature Reviews. Clinical Oncology|January 26, 2024
BRAF - a tumour-agnostic drug target with lineage-specific dependenciesAphrothiti J Hanrahan, Ziyu Chen, Neal Rosen, et al.
Cancer Research|November 18, 2008
Genetic predictors of MEK dependence in non-small cell lung cancerChristine A Pratilas, Aphrothiti J Hanrahan, Ensar Halilovic, et al.
Cancer Research|March 1, 2014
Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependenceMoriah H Nissan, Christine A Pratilas, Alexis M Jones, et al.
Molecular Cancer Research : MCR|December 11, 2020
AKT1 E17K Inhibits Cancer Cell Migration by Abrogating β-Catenin SignalingSizhi Paul Gao, Amber J Kiliti, Kai Zhang, et al.
Science (New York, N.Y.)|August 28, 2012
Genome sequencing identifies a basis for everolimus sensitivityGopa Iyer, Aphrothiti J Hanrahan, Matthew I Milowsky, et al.
Nature Genetics|December 1, 2009
Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignanciesSelvaraju Veeriah, Barry S Taylor, Shasha Meng, et al.
Cancer Cell|November 6, 2018
Widespread Selection for Oncogenic Mutant Allele Imbalance in CancerCraig M Bielski, Mark T A Donoghue, Mayur Gadiya, et al.
Cancer Discovery|February 14, 2012
Genomic complexity and AKT dependence in serous ovarian cancerAphrothiti J Hanrahan, Nikolaus Schultz, Maggie L Westfal, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancer Research|January 5, 2022
BRAF Mutations: The Discovery of Allele- and Lineage-Specific DifferencesAphrothiti J Hanrahan, David B Solit
Cancer Discovery|August 14, 2012
RAF/MEK dependence of KRAS-mutant pancreatic ductal adenocarcinomasAphrothiti J Hanrahan, David B Solit
Nature Reviews. Clinical Oncology|January 26, 2024
BRAF - a tumour-agnostic drug target with lineage-specific dependenciesAphrothiti J Hanrahan, Ziyu Chen, Neal Rosen, et al.
Cancer Research|November 18, 2008
Genetic predictors of MEK dependence in non-small cell lung cancerChristine A Pratilas, Aphrothiti J Hanrahan, Ensar Halilovic, et al.
Cancer Research|March 1, 2014
Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependenceMoriah H Nissan, Christine A Pratilas, Alexis M Jones, et al.
Molecular Cancer Research : MCR|December 11, 2020
AKT1 E17K Inhibits Cancer Cell Migration by Abrogating β-Catenin SignalingSizhi Paul Gao, Amber J Kiliti, Kai Zhang, et al.
Science (New York, N.Y.)|August 28, 2012
Genome sequencing identifies a basis for everolimus sensitivityGopa Iyer, Aphrothiti J Hanrahan, Matthew I Milowsky, et al.
Nature Genetics|December 1, 2009
Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignanciesSelvaraju Veeriah, Barry S Taylor, Shasha Meng, et al.
Cancer Cell|November 6, 2018
Widespread Selection for Oncogenic Mutant Allele Imbalance in CancerCraig M Bielski, Mark T A Donoghue, Mayur Gadiya, et al.
Cancer Discovery|February 14, 2012
Genomic complexity and AKT dependence in serous ovarian cancerAphrothiti J Hanrahan, Nikolaus Schultz, Maggie L Westfal, et al.
Pageof 2